Web-Books
in the Austria-Forum
Austria-Forum
Web-Books
Medizin
Advances in Neuroimmunology
Page - 56 -
  • User
  • Version
    • full version
    • text only version
  • Language
    • Deutsch - German
    • English

Page - 56 - in Advances in Neuroimmunology

Image of the Page - 56 -

Image of the Page - 56 - in Advances in Neuroimmunology

Text of the Page - 56 -

BrainSci. 2016,6, 41 Fractalkine isaproteinexpressedconstitutivelybyneurons inamembraneboundformthatcan becleavedbydisintegrinandmetalloproteinase(ADAM)10and17.Thisproteolysisreleasesasoluble formoftheprotein,butbothisoformsarethoughtto ligate thecognatereceptor,CX3CR1, locatedonthe surfaceofmicroglia in theCNS[42]. Thisneuron-glia interactionservesasan importantendogenous mechanismtosuppressmicroglialactivationandregulatetheoutputofinflammatorymediatorsandother damagingmolecules[42]. IthasbeenshownthatincreasingfractalkinelevelsusinganAAV9genetherapy approachcanbeneuroprotective[35,36],whiletheabsenceofthisFKN-CX3CR1signalingcascadeconfers susceptibility toneurodegeneration in rodentmodels of PD.Cardonaetal. (2006) demonstrated that CX3CR1deficiencyleadtoincreaseneurotoxicitytobothperipheralLPSandMPTPinjections. Inthese experiments,bothheterozygousandhomozygousmiceexhibitedincreasedneurodegenerationandIL-1β expressioncomparedtotheintactwild-typecontrols [43]. Thereisevidenceindicatingthatfractalkinecan regulatemicroglial functionandsubsequentlyreduceinflammationintheCNS.Multiple invitrostudies haveestablishedthatenhancingfractalkinesignalingthroughapplicationof the ligandorstimulation of the receptor canprotect against cell death in culture; FKN-liganddecreasesmicroglial apoptosis andprotectsagainstneurotoxicitybybothLPSandTNF-α. Ithasbeendemonstratedthatmaintaining or enhancing communication of FKN/CX3CR1 is neuroprotective inmultiple rodentmodels of PD. Pabonetal. (2011) [37]attenuatedtheneurotoxicityof6hydroxydopamine(6OHDA)bydelivering achronic intrastriatal infusionofrecombinant fractalkine ligand. Thispreservationofdopaminergic terminals in thestriatumwasalsoassociatedwithdecreasedmicroglialactivationaroundthe lesion site, indicatedbyareducedexpressionof theMHCIIsurfacemarker. Tofurtherexaminetheaction of fractalkine inamodelofPDwheresynuclein is introduced in theSNviaAAV,Nashetal. (2015) corroboratedtheneuroprotectiveeffectsofFKNbyusingaviralvector tooverexpress thedifferent isoformsofFKN;membrane-bound(mFKN)orthesolubleportion(sFKN).Inthisstudy,sFKNreduced DAcell death in young ratswith overexpressionα-syn in the SNviaAAV9. Thesefindingsmay bedue toalteredFKN-CX3CR1signaling [44] anda reduction inpro-inflammatory cytokines and modulationofmicroglial function intoamoreprotective role (Figure1). These results suggest that supraphysiological levelsof the fractalkineareprotectiveagainst theneurodegenerationoccurring in twoseparateexperimentalmodelsofPD.Morgantietal. (2012) [36]also illustratedthe importance ofneuron-glial communicationbyadministeringMPTPtoanimalsdeficient in the fractalkine ligand. TheseFKNknockoutswereextremelysusceptible toMPTPtoxicity,anddisplaybothadramatic loss ofTHintheSNandtherobustgliosisassociatedwith the lesionsite.Notonlydoes thiswork indicate thatFKN-CX3CR1communication isnecessary formoderatingcelldeathandsubsequentdetrimental inflammatory events, but it also suggests that further enhancing or supplementing this signaling pathwayabovebaselineactivity is sufficient toachieveneuroprotectionagainst thesepotent toxins (Figure1). However, theactionof fractalkine isquite complex;CX3CR1knockoutmicehavebeen shownto increasephagocytosisofamyloid,butdecreasephagocytosisof synuclein [44]. It isunclear if thisaction ismediatedbymembraneboundfractalkineor thecleaved, soluble form. Several studies have triedtoclarify therolesof thedifferentialprocessingof fractalkineandtheredoesnotappear to beaclearconclusionat thispoint.Whenanobligatesolubleversionof fractalkine isused,asdescribed herewithagene therapyapproach, ithasbeenshowntobebeneficial inmodelsofPDandADtau pathology[35,36,45].However, inothermodelswhereanobligatesoluble fractalkinemouse isused, oppositeresultshavebeenobserved,andthispaperconcludesthat themembraneanchoredfractalkine isassociatedwithphagocytosisofAβ [46]. Much of the current data regarding the therapeutic potential of FKN in the treatment of inflammatoryandneurodegenerativeconditionsstemsfromstudiesinvolvingyounganimals.However, it is essential to note that aged microglia have been shown to be resistant to their regulatory signals [20,47]. Furthermore,communicationvia theFKN/CX3CR1axisbecomesdysregulatedwith ageandcanalsocontribute tomicroglialpriminganddysfunction. Thereareageassociatedchanges affectingboth the ligandand receptor. It has beenhas shown that FKN is reducedby in the aged hippocampus [48], although the extent of FKN downregulation in the SN has not yet been fully 56
back to the  book Advances in Neuroimmunology"
Advances in Neuroimmunology
Title
Advances in Neuroimmunology
Author
Donna Gruol
Editor
MDPI
Location
Basel
Date
2017
Language
English
License
CC BY-NC-ND 4.0
ISBN
978-3-03842-571-7
Size
17.0 x 24.0 cm
Pages
164
Keywords
neuroimmune, cytokine, chemokine, glia cel, neuron, neurodevelopment, neuroimmune disorder, neurologic disease, psychiatric disease, neuronal injury
Category
Medizin
Web-Books
Library
Privacy
Imprint
Austria-Forum
Austria-Forum
Web-Books
Advances in Neuroimmunology